[Risk factors associated with the progression of chronic HBV infection in patients with normal ALT].

Abstract

Hepatitis B virus (HBV) infection is one of the common causes of chronic hepatitis in China. Active antiviral therapy can effectively reduce the occurrence risk of end-stage liver diseases, such as decompensated cirrhosis, liver failure and hepatocellular carcinoma. The existing international and domestic guidelines for the prevention and treatment of chronic hepatitis B recommends regular follow-up for patients with normal alanine aminotransferase (ALT). Studies have shown that a high percentage (25.4%-88.9%) of patients with chronic HBV infection have normal ALT levels; however, hepatic histopathology revels obvious inflammation, fibrosis (G≥2 and/or S≥2), cirrhosis and liver cancer. In this paper, we reviewed the relatively insidious risk factors associated with the progression of chronic HBV infection in patients with normal ALT.

• Authors: L Wei, H Li, P Hu
• Journal: Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology (Zhonghua Gan Zang Bing Za Zhi) Vol. 28 Issue 12 Pg. 995-998 (Dec 20 2020) ISSN: 1007-3418 [Print] China
• PMID: 34865345 (Publication Type: Journal Article, Review)

Topics

• End Stage Liver Disease
• Hepatitis B virus
• Hepatitis B, Chronic (epidemiology)
• Humans
• Liver Cirrhosis
• Risk Factors